Search research articles
Contact Us
Filters
Showing results (1211-1220 of 1,751) with videos related to
Page
of 176
Sort By:
Social Psychiatry and Psychiatric Epidemiology
|
October 1, 2024
Perception of one's social environment and loneliness: results of the nationally representative "Old age in Germany (D80+)" study
André Hajek, Angelina Sutin, Martina Luchetti, et al.
Science Advances
|
July 21, 2023
Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer
Xudong Zhang, Jun Yao, Xiaoran Li, et al.
BMC Public Health
|
April 4, 2019
Randomised controlled trial and economic evaluation of a task-based weight management group programme
Hayden McRobbie, Peter Hajek, Sarrah Peerbux, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
November 13, 2014
Social competence following neonatal and childhood stroke
Warren Lo, Anne Gordon, Christine Hajek, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
September 23, 2003
Results of therapy and changing prognosis of multiple myeloma during the last 40 years in the region of North and Middle Moravia: group of 562 patients
Vlastimil Scudla, Jaroslav Bacovsky, Karel Indrak, et al.
Bioresources and Bioprocessing
|
July 7, 2017
Beechwood carbohydrates for enzymatic synthesis of sustainable glycolipids
Sascha Siebenhaller, Tatjana Hajek, Claudia Muhle-Goll, et al.
Blood Cancer Journal
|
February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
Heinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.
Age and Ageing
|
October 17, 2017
Frailty and healthcare costs-longitudinal results of a prospective cohort study
André Hajek, Jens-Oliver Bock, Kai-Uwe Saum, et al.
Haematologica
|
September 17, 2013
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
Ludek Pour, Sabina Sevcikova, Henrieta Greslikova, et al.
Leukemia & Lymphoma
|
October 23, 2013
Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial
Meletios A Dimopoulos, Antonio Palumbo, Roman Hajek, et al.
Page
of 176
Search research articles
Search
Showing results (1211-1220 of 1,751) with videos related to
Sort By:
Page
of 176
Social Psychiatry and Psychiatric Epidemiology
|
October 1, 2024
Perception of one's social environment and loneliness: results of the nationally representative "Old age in Germany (D80+)" study
André Hajek, Angelina Sutin, Martina Luchetti, et al.
Science Advances
|
July 21, 2023
Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer
Xudong Zhang, Jun Yao, Xiaoran Li, et al.
BMC Public Health
|
April 4, 2019
Randomised controlled trial and economic evaluation of a task-based weight management group programme
Hayden McRobbie, Peter Hajek, Sarrah Peerbux, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
November 13, 2014
Social competence following neonatal and childhood stroke
Warren Lo, Anne Gordon, Christine Hajek, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
September 23, 2003
Results of therapy and changing prognosis of multiple myeloma during the last 40 years in the region of North and Middle Moravia: group of 562 patients
Vlastimil Scudla, Jaroslav Bacovsky, Karel Indrak, et al.
Bioresources and Bioprocessing
|
July 7, 2017
Beechwood carbohydrates for enzymatic synthesis of sustainable glycolipids
Sascha Siebenhaller, Tatjana Hajek, Claudia Muhle-Goll, et al.
Blood Cancer Journal
|
February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
Heinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.
Age and Ageing
|
October 17, 2017
Frailty and healthcare costs-longitudinal results of a prospective cohort study
André Hajek, Jens-Oliver Bock, Kai-Uwe Saum, et al.
Haematologica
|
September 17, 2013
Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse
Ludek Pour, Sabina Sevcikova, Henrieta Greslikova, et al.
Leukemia & Lymphoma
|
October 23, 2013
Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial
Meletios A Dimopoulos, Antonio Palumbo, Roman Hajek, et al.
Page
of 176